Search results for "From ACP Internist"
Antidepressants associated with decreased mortality rates in patients with diabetes and depression
A retrospective cohort study in Taiwan found that antidepressant use was associated with a significantly reduced risk for death, and after adjustment, total mortality decreased as total cumulative antidepressant dose increased.
https://diabetes.acponline.org/archives/2019/07/12/7.htm
12 Jul 2019
Analysis finds several treatments for painful diabetic neuropathy more effective than placebo
A large meta-analysis recently compared the effectiveness of pharmacological treatments for painful diabetic neuropathy.
https://diabetes.acponline.org/archives/2014/11/14/5.htm
14 Nov 2014
Text messages may improve glycemic control in patients with diabetes and coronary disease
Patients in a Chinese study received six automated text messages per week with educational and motivational information on glucose monitoring, blood pressure control, medication adherence, physical activity, and lifestyle.
https://diabetes.acponline.org/archives/2019/09/13/9.htm
13 Sep 2019
Targeting social needs may help improve type 2 diabetes outcomes, review finds
A systematic review found that HbA1c levels were improved significantly by food supplementation with referral and diabetes support, financial incentives with education and skills training, housing relocation with counseling support, and the integration of nonmedical interventions into medical care.
https://diabetes.acponline.org/archives/2022/07/08/6.htm
8 Jul 2022
Regular use of PPIs linked to increased risk of type 2 diabetes
In an analysis of the Nurses' Health and Health Professionals studies, regular users of proton-pump inhibitors (PPIs) had a 24% higher risk of diabetes than nonusers, with longer duration of use associated with greater risk.
https://diabetes.acponline.org/archives/2020/10/09/9.htm
9 Oct 2020
SGLT-2 inhibitors associated with lower risk of gout vs. GLP-1 receptor agonists
In a large, propensity-matched study, adult patients with type 2 diabetes who were newly prescribed a sodium-glucose cotransporter-2 (SGLT-2) inhibitor had a lower rate of incident gout than those newly prescribed a glucagon-like peptide-1 (GLP-1) receptor agonist.
https://diabetes.acponline.org/archives/2020/02/14/7.htm
14 Feb 2020
Nearly 50% of older U.S. adults reported taking aspirin preventively
A study of National Health and Nutrition Examination Survey data from 2011 to 2018 found that 46.7% of respondents ages 60 years and older used aspirin for primary or secondary cardiovascular disease prevention and suggested potential overuse in certain groups.
https://diabetes.acponline.org/archives/2021/07/09/7.htm
9 Jul 2021
GLP-1 analogues may be associated with bile duct, gallbladder disease
Current use of DPP-4 inhibitors was not associated with increased risk for bile duct and gallbladder disease versus current use of at least 2 oral antidiabetic drugs, but an increased risk was seen with use of GLP-1 analogues.
https://diabetes.acponline.org/archives/2016/08/12/7.htm
12 Aug 2016
Patients on tramadol more likely to be hospitalized for hypoglycemia
Patients who began taking tramadol were significantly more likely to be hospitalized for hypoglycemia than those prescribed codeine, a recent study found.
https://diabetes.acponline.org/archives/2015/01/09/6.htm
9 Jan 2015
GLP-1 receptor agonists associated with thyroid cancer
Patients taking a glucagon-like peptide-1 (GLP-1) receptor agonist had about one and a half times the risk of developing thyroid cancer compared to similar controls, according to an observational French study.
https://diabetes.acponline.org/archives/2022/12/09/6.htm
9 Dec 2022